Terbinafine: Mode of action and properties of the squalene epoxidase inhibition
暂无分享,去创建一个
[1] N. Ryder. The mechanism of action of terbinafine , 1989, Clinical and experimental dermatology.
[2] J Drews,et al. In vitro activity of naftifine, a new antifungal agent , 1981, Antimicrobial Agents and Chemotherapy.
[3] N. Ryder. Mechanism of action of the allylamine antimycotics , 1987 .
[4] U. Sleytr,et al. Morphological changes induced by Naftifine, a new antifungal agent, in Trichophyton mentagrophytes. , 1981, The Journal of investigative dermatology.
[5] N S Ryder,et al. Properties of a particulate squalene epoxidase from Candida albicans. , 1984, Biochimica et biophysica acta.
[6] N. Ryder,et al. Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans , 1984, Antimicrobial Agents and Chemotherapy.
[7] G. Petrányi,et al. Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.
[8] D. Back,et al. Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro. , 1989, British journal of clinical pharmacology.
[9] R. S. Burden,et al. The lipid compositions of two isolates of Cladosporium cucumerinum do not explain their differences in sensitivity to fungicides which inhibit sterol biosynthesis , 1989 .
[10] I. Schuster. The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.
[11] N. Ryder. Mechanism of Action and Biochemical Selectivity of Allylamine Antimycotic Agents , 1988, Annals of the New York Academy of Sciences.
[12] N. Ryder. Biochemical mode of action and enantiomeric selectivity of SDZ 89-485, a new triazole antimycotic. , 1990, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[13] N. Ryder. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent , 1985, Antimicrobial Agents and Chemotherapy.
[14] N S Ryder,et al. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. , 1984, Science.
[15] N. Ryder. Squalene Epoxidase — Enzymology and Inhibition , 1990 .
[16] N. Ryder. Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. , 1985, Journal of General Microbiology.
[17] A. Stütz. Synthesis and Structure‐ Activity Correlations within Allylamine Antimycotics , 1988, Annals of the New York Academy of Sciences.
[18] N. Ryder. Squalene epoxidase as a target for the allylamines. , 1991, Biochemical Society transactions.
[19] N. Ryder. Squalene epoxidase as the target of antifungal allylamines , 1987 .
[20] E. Mercer,et al. Location of squalene accumulation and physiological effects of ergosterol depletion in naftifine-grown yeast , 1988 .
[21] N S Ryder,et al. Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes. , 1985, The Biochemical journal.
[22] M. Schaude,et al. Inhibitory Effect of Antifungal Agents on Germ Tube Formation in Candida albicans. Hemmeffekt antifungaler Wirkstoffe auf die Keimschlauchbildung von Candida albicans , 1987, Mykosen.
[23] P. Leroux,et al. Resistance to inhibitors of sterol biosynthesis in field isolates or laboratory strains of the eyespot pathogen Pseudocercosporella herpotrichoides , 1988 .
[24] N. Ryder,et al. Allylamine antifungal drugs. , 1992, Current topics in medical mycology.